Observation on the Efficacy of Radiofrequency Ablation for Patients With Moderate to Severe Gastric Atrophy With Enterosis With or Without Atrophy of Intraepithelial Neoplasia: An Observational Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorXiuli Zuo

About this trial

The aim of this observational study was to understand the effect of radiofrequency ablation on subjects with moderate to severe gastric atrophy with enterocolitis with or without low-grade intraepithelial neoplasia who underwent radiofrequency ablation. The main question it aims to answer is:

Does radiofrequency ablation therapy reduce gastric mucosal atrophy and enterosis in subjects with moderate to severe gastric atrophy with enterosis with or without low-grade intraepithelial neoplasia?

Eligibility criteria

Qualifiers

Age 18-70 years old, male or female.

Patients who had undergone gastroscopy within 3 months prior to inclusion, and whose histologic diagnosis of chronic gastritis was histologically atrophic enterocolitis graded at moderate-to-severe with or without low-grade intraepithelial neoplasia.

Patients who had undergone gastroscopy within 3 months prior to inclusion, and whose OLGA (atrophic grading and staging criteria for chronic gastritis) or OLGIM (enteric grading and staging criteria for chronic gastritis) staging criteria had reached moderately severe.

Helicobacter pylori negative.

Disqualifiers

Pregnant or lactating women.

Previous history of malignant tumors of the digestive tract or history of gastrointestinal surgery.

Malignant tumors of other organs, coagulation disorders, cardiopulmonary insufficiency, hepatic and renal insufficiency, etc.

Those who are unable or unwilling to sign the informed consent form.

Trial design

Treatments tested in this trial

  • Radiofrequency ablation alone

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Xiuli Zuo

Lead sponsor

Shandong University

Sponsor institution